CONMED (CNMD) vs Medtronic (MDT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CONMED (CNMD) has outperformed Medtronic (MDT) over the past year, losing 3.6% versus a loss of 13.0%. Over five years, MDT leads with a -33.1% price change compared with -68.9% for CNMD. Medtronic is the larger company by market cap ($111.80 billion vs $1.35 billion), about 83.1 times the size.
On valuation, CONMED trades at a lower forward P/E (9.4x vs 13.6x for Medtronic). Medtronic offers the higher dividend yield (3.26% vs 0.45%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNMD | MDT |
|---|---|---|
| Share price | $44.93 | $87.40 |
| Market cap | $1.35B | $111.80B |
| 1-day change | +1.58% | +2.21% |
| YTD return | +8.94% | -10.98% |
| 1-year return | -3.64% | -13.04% |
| 5-year return | -68.86% | -33.06% |
| P/E ratio (TTM) | 24.29 | 21.47 |
| Forward P/E | 9.40 | 13.63 |
| EPS (TTM) | $1.85 | $4.07 |
| Dividend yield | 0.45% | 3.26% |
| Annual dividend | $0.20 | $2.85 |
| Revenue (latest FY) | — | $36.36B |
| Revenue growth (YoY) | — | +8.43% |
| Net income (latest FY) | — | $4.80B |
| Gross margin | — | 65.02% |
| Operating margin | — | 17.78% |
| Net margin | — | 13.20% |
| 52-week high | $53.66 | $106.33 |
| 52-week low | $31.44 | $73.31 |
| Distance from 52-week high | -16.27% | -17.80% |
| Analyst consensus | none | buy |
| Avg. price target upside | +1.27% | +19.50% |
| Average volume | 493.66K | 11.49M |
| Shares outstanding | 29.95M | 1.28B |
| Employees | 3,900 | 95,000 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Medtronic is about 83.1 times larger than CONMED by market value ($111.80B vs $1.35B).
- Medtronic offers a meaningfully higher dividend yield (3.26% vs 0.45%).
About CONMED
CNMD stock →CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 3,900 employees
About Medtronic
MDT stock →Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 95,000 employees
CNMD vs MDT FAQ
Which is bigger, CONMED or Medtronic?
Medtronic (MDT) is larger, with a market capitalization of $111.80B compared with $1.35B for CONMED (CNMD).
Which stock has performed better over the past year, CNMD or MDT?
CNMD returned -3.64% over the past 12 months, compared with -13.04% for MDT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CNMD or MDT?
MDT has the lower trailing P/E at 21.5, versus 24.3 for CNMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, CONMED or Medtronic?
Medtronic has the higher yield at 3.26%, compared with 0.45% for CONMED.
Are CONMED and Medtronic in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.